Press releases | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Press releases

PRESS RELEASE

published on 02/11/2026 at 17:45, 7 months ago

Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Disclosure of total voting rights and shares as of Jan 31, 2026 by Median Technologies. Cutting-edge AI for cancer diagnoses and treatments. Listed on Euronext Growth market

Voting Rights Shares AI Median Technologies Cancer Diagnoses
PRESS RELEASE

published on 02/11/2026 at 17:00, 7 months ago

Mutares has completed the acquisition of Venator Ultramarine Blue Pigments business from Venator France SAS
Mutares completes acquisition of Venator Ultramarine Blue Pigments business from Venator France SAS, strengthening Chemicals & Materials segment with strategic move into specialty chemicals industry

Acquisition Specialty Chemicals Mutares Venator Chemicals & Materials
PRESS RELEASE

published on 02/11/2026 at 16:40, 7 months ago

Guidepoint Launches Guidepoint360 Mobile App, Delivering AI-Driven Research Whenever It's Needed
Guidepoint launches Guidepoint360 mobile app, providing AI-driven research on-the-go. The app offers real-time expert intelligence for institutional investors, consulting firms, and enterprises, facilitating high-stakes decisions under tight timelines

Mobile App AI-driven Research Guidepoint Guidepoint360 Expert Intelligence
PRESS RELEASE

published on 02/11/2026 at 16:00, 7 months ago

Eleving Group: the recording of 12M 2025 earnings call
Eleving Group organized the 12M 2025 earnings call, presenting unaudited financial results and achievements, available for viewing. The company operates in 17 countries, offering financial services

Financial Results Technology Earnings Call Eleving Group International Finance
PRESS RELEASE

published on 02/11/2026 at 16:00, 7 months ago

Information relative au nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2026
Arcure, spécialiste de l'intelligence artificielle pour l'industrie, coté sur Euronext Growth Paris (FR0013398997), présente son activité et ses résultats financiers

Chiffre D'affaires Euronext Growth Intelligence Artificielle Arcure FR0013398997
PRESS RELEASE

published on 02/11/2026 at 15:04, 7 months 1 day ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
The Vanguard Group, Inc. discloses a 5.08% stake in JTC plc through 8,756,673 shares with a position date of 10 February 2026

The Vanguard Group Stake Disclosure 5.08% JTC Plc 8,756,673 Shares
PRESS RELEASE

published on 02/11/2026 at 15:03, 7 months 1 day ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
The Vanguard Group, Inc. discloses 5.54% stake in Avadel Pharmaceuticals plc as of 10 Feb 2026. Form 8.3 filed with the Irish Takeover Panel

Form 8.3 Irish Takeover Panel The Vanguard Group Stake Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE

published on 02/11/2026 at 15:02, 7 months 1 day ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc as of 10-Feb-2026

Relevant Securities The Vanguard Group Ownership Disclosure Financial Disclosure Beazley Plc
PRESS RELEASE

published on 02/11/2026 at 14:59, 7 months 1 day ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Public disclosure under Rule 8.3 of the Takeover Code on 11 Feb 2026

Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE

published on 02/11/2026 at 14:58, 7 months 1 day ago

Form 8.3 - The Vanguard Group, Inc.: Just Group plc
The Vanguard Group, Inc. discloses 4.93% ownership in Just Group plc in a Form 8.3 filing. Public position disclosure under Rule 8.3 of the Takeover Code

Form 8.3 Takeover Code Vanguard Group Ownership Disclosure Just Group Plc

Accesswire

Published on 09/12/2026 at 02:35, 13 hours 9 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 16 hours 44 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 17 hours 39 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 18 hours 19 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 22 hours 44 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 8 hours 14 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 17 hours 29 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 17 hours 34 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 20 hours ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 21 hours 29 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 8 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 8 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 8 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 8 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 20 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE